Adar1 Capital Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $652 Billion distributed in 210 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Keros Therapeutics, Inc. with a value of $71.9B, Protagonist Therapeutics, Inc with a value of $52.4B, Ea Series Trust with a value of $38B, Zai Lab LTD with a value of $29.7B, and Abivax Sa with a value of $23.5B.

Examining the 13F form we can see an increase of $113B in the current position value, from $539B to 652B.

Adar1 Capital Management, LLC is based out at Austin, TX

Below you can find more details about Adar1 Capital Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $652 Billion
Healthcare: $418 Billion
ETFs: $56.4 Billion
Basic Materials: $135 Million

Stock Holdings Table Market Cap. of $300 Millions to $2 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 210
  • Current Value $652 Billion
  • Prior Value $539 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 43 stocks
  • Additional Purchases 61 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 53 stocks
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.